4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0002029985-26-000002
Options or other derivatives
- SVP, CMC & Formulation acquired 69,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tenjarla Srini SVP, CMC & Formulation | 2026-02-03 | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | D | ||
Loading xslF345X05/wk-form4_1771334956.xml…